Zhang Jun, Wang Yu, Zhang Wei, Cai Linglong, Feng Jianglong, Zhu Yiwei, Lu Hongguang
Department of Dermatology, the Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
Department of Pathology, the Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
Clin Cosmet Investig Dermatol. 2024 Feb 26;17:465-476. doi: 10.2147/CCID.S451288. eCollection 2024.
The rising incidence and mortality associated with cutaneous malignant tumours highlight the importance of early diagnosis of these tumors. In clinical practice, these tumors are often misdiagnosed as benign skin lesions such as melanocytic nevi (MN) and seborrheic keratosis (SK) because of their similar morphologic features. The incidence and clinicopathological subtypes of cutaneous malignancies in East Asia populations significantly differ from those in fair-skinned groups. However, studies on misdiagnoses in Eastern countries are lacking. Therefore, this study focused on the clinical and pathological features of cutaneous malignant tumors misdiagnosed as MN or SK in a Chinese population.
A total of 4592 samples clinically diagnosed as MN (n = 3503) or SK (n = 1089) from July 2014 to June 2022 were collected and evaluated retrospectively. The clinical and pathological data were analyzed to identify associated factors.
Pathological assessments showed that 2.5% (86/3503) of the specimens clinically diagnosed as MN were malignancies, predominantly basal cell carcinoma (BCC, 84.9%, 73/86), followed by malignant melanoma (MM, 8.1%, 7/86) and squamous cell carcinoma (SCC, 7.0%, 6/86). Similarly, 5.7% (62/1089) of the specimens clinically diagnosed as SK were malignant tumors, of which BCC (50.0%, 31/62) was the most common, followed by SCC (41.9%, 26/62) and MM (8.1%, 5/62). In both types of specimens, advanced age and facial lesions were risk factors for malignancy misdiagnosis. The malignancy rate, mean age, and proportion of SCC in the specimens clinically diagnosed as SK were higher than those in the specimens clinically diagnosed as MN. Dermoscopy significantly reduced the rate of misdiagnosis of these tumors as MN or SK.
In China, cutaneous malignant tumors misdiagnosed as MN or SK are not uncommon in clinical practice, and active introduction of noninvasive diagnostic techniques is essential to distinguish them.
皮肤恶性肿瘤的发病率和死亡率不断上升,凸显了早期诊断这些肿瘤的重要性。在临床实践中,由于形态学特征相似,这些肿瘤常被误诊为良性皮肤病变,如黑素细胞痣(MN)和脂溢性角化病(SK)。东亚人群皮肤恶性肿瘤的发病率和临床病理亚型与白种人群有显著差异。然而,目前缺乏关于东方国家误诊情况的研究。因此,本研究聚焦于中国人群中被误诊为MN或SK的皮肤恶性肿瘤的临床和病理特征。
回顾性收集并评估了2014年7月至2022年6月期间临床诊断为MN(n = 3503)或SK(n = 1089)的4592份样本。分析临床和病理数据以确定相关因素。
病理评估显示,临床诊断为MN的标本中有2.5%(86/3503)为恶性肿瘤,主要为基底细胞癌(BCC,84.9%,73/86),其次是恶性黑色素瘤(MM,8.1%,7/86)和鳞状细胞癌(SCC,7.0%,6/86)。同样,临床诊断为SK的标本中有5.7%(62/1089)为恶性肿瘤,其中BCC(50.0%,31/62)最为常见,其次是SCC(41.9%,26/62)和MM(8.1%,5/62)。在这两种类型的标本中,高龄和面部病变是恶性肿瘤误诊的危险因素。临床诊断为SK的标本中的恶性率、平均年龄和SCC比例均高于临床诊断为MN的标本。皮肤镜检查显著降低了这些肿瘤被误诊为MN或SK的比例。
在中国,临床实践中被误诊为MN或SK的皮肤恶性肿瘤并不少见,积极引入非侵入性诊断技术对于鉴别它们至关重要。